Osaic Holdings’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-87
Closed -$61 7516
2023
Q4
$61 Hold
87
﹤0.01% 7153
2023
Q3
$60 Hold
87
﹤0.01% 7265
2023
Q2
$210 Sell
87
-1
-1% -$4 ﹤0.01% 7198
2023
Q1
$718 Sell
88
-2
-2% -$27 ﹤0.01% 7057
2022
Q4
$1K Sell
90
-56
-38% -$640 ﹤0.01% 7024
2022
Q3
$2K Hold
146
﹤0.01% 6879
2022
Q2
$5K Sell
146
-35
-19% -$1.09K ﹤0.01% 6522
2022
Q1
$7K Hold
181
﹤0.01% 6359
2021
Q4
$8K Buy
181
+14
+8% +$873 ﹤0.01% 6428
2021
Q3
$11K Buy
167
+36
+27% +$2.63K ﹤0.01% 6163
2021
Q2
$10K Buy
131
+57
+77% +$3.47K ﹤0.01% 6094
2021
Q1
$5K Sell
74
-128
-63% -$9.97K ﹤0.01% 6198
2020
Q4
$7K Buy
202
+127
+169% +$5.65K ﹤0.01% 5679
2020
Q3
$4K Sell
75
-42
-36% -$2.49K ﹤0.01% 5676
2020
Q2
$4K Hold
117
﹤0.01% 5601
2020
Q1
$3K Buy
+117
New +$4.96K ﹤0.01% 5601

Other funds holding DMK

Osaic Holdings's DMK Position: Q1 2024 in Review

Osaic Holdings sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 87 shares — an estimated $61 sold.

Osaic Holdings first reported a position in DMK in Q1 2020 and held it in 16 quarters. The position peaked at $11K in Q3 2021. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Osaic Holdings reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 87 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $61.
  • Osaic Holdings first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's DMK Pharmaceuticals Corporation Common Stock position peaked at $11K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.